San Diego-primarily based Viking Therapeutics marked itself as a serious competitor from the weight loss drug market place in February just after revealing promising details from a mid-phase demo of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when specified as being a weekly injection As well as in Ma